Health care companies by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Centene has the lowest figure of the 154 health care companies ranked by P/S ratio, at 0.2, followed by Cencora (0.2) and Molina Healthcare (0.2). Figures as of 19 Nov 2026, 21:37 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 154
- Lowest
- Centene0.2
- Median
- 4.2
- Combined market value
- CZK 198.68T
- Countries
- 14
- Not ranked
- 16no P/S ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/S ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | IlluminaILMN · Health Care | 7.0 | CZK 675.7B | CZK 4,468.59 | 4.45% down | 76% up | ||
| 102 | Medpace HoldingsMEDP · Health Care | 7.0 | CZK 394.9B | CZK 14,118.73 | 1.99% down | 10% up | ||
| 103 | Gilead SciencesGILD · Health Care | 7.0 | CZK 4.6T | CZK 3,708.62 | 1.45% down | 35% up | ||
| 104 | Agilent TechnologiesA · Health Care | 7.1 | CZK 1.1T | CZK 3,904.82 | 1.12% down | 22% up | ||
| 105 | Arrowhead PharmaceuticalsARWR · Health Care | 7.4 | CZK 137.4B | CZK 972.09 | 1.25% up | 13% up | ||
| 106 | United TherapeuticsUTHR · Health Care | 7.5 | CZK 530.3B | CZK 12,451.16 | 3.16% down | 22% up | ||
| 107 | Halozyme TherapeuticsHALO · Health Care | 7.6 | CZK 236.2B | CZK 2,072.00 | 2.88% down | 39% up | ||
| 108 | AbbVieABBV · Health Care | 8.2 | CZK 11.16T | CZK 6,314.44 | 0.86% down | 25% up | ||
| 109 | Mettler-Toledo InternationalMTD · Health Care | 8.4 | CZK 755.5B | CZK 37,985.05 | 1.82% down | 24% up | ||
| 110 | GenmabGMAB · Health Care | 8.5 | CZK 705.1B | CZK 1,143.56 | 0.75% up | 70% up | ||
| 111 | BeOne MedicinesONC · Health Care | 8.5 | CZK 1.02T | CZK 8,901.32 | 0.97% down | 16% up | ||
| 112 | PenumbraPEN · Health Care | 9.0 | CZK 280.9B | CZK 7,126.62 | 0.18% down | 15% up | ||
| 113 | West Pharmaceutical ServicesWST · Health Care | 9.0 | CZK 615.4B | CZK 8,834.29 | 1.81% down | 57% up | ||
| 114 | Corcept TherapeuticsCORT · Health Care | 9.3 | CZK 158.4B | CZK 1,447.10 | 4.15% down | 10% down | ||
| 115 | Bio-TechneTECH · Health Care | 9.4 | CZK 254.3B | CZK 1,619.03 | 0.07% down | 24% up | ||
| 116 | Travere TherapeuticsTVTX · Health Care | 9.4 | CZK 103.3B | CZK 1,075.64 | 3.86% down | 45% up | ||
| 117 | Madrigal PharmaceuticalsMDGL · Health Care | 9.6 | CZK 205.2B | CZK 8,835.40 | 0.34% down | 27% down | ||
| 118 | Edwards LifesciencesEW · Health Care | 9.8 | CZK 1.33T | CZK 2,313.41 | 1.28% down | 25% up | ||
| 119 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 10.8 | CZK 163.7B | CZK 2,083.02 | 1.59% down | 129% up | ||
| 120 | Vertex PharmaceuticalsVRTX · Health Care | 11.0 | CZK 2.94T | CZK 11,595.10 | 2.94% down | 27% up | ||
| 121 | Axsome TherapeuticsAXSM · Health Care | 11.2 | CZK 158.9B | CZK 3,021.59 | 1.25% up | 6% down | ||
| 122 | 10x GenomicsTXG · Health Care | 11.7 | CZK 168.1B | CZK 1,277.85 | 0.54% up | 247% up | ||
| 123 | Mirum PharmaceuticalsMIRM · Health Care | 12.0 | CZK 138.9B | CZK 2,127.01 | 3.27% up | 34% up | ||
| 124 | IDEXX LaboratoriesIDXX · Health Care | 12.6 | CZK 1.21T | CZK 15,358.51 | 1.26% down | 1% up | ||
| 125 | Intuitive SurgicalISRG · Health Care | 14.0 | CZK 3.14T | CZK 9,069.23 | 3.26% down | 24% down | ||
| 126 | BillionToOneBLLN · Health Care | 14.1 | CZK 96B | CZK 2,008.75 | 1.46% down | 4% down | ||
| 127 | argenxARGX · Health Care | 14.3 | CZK 1.32T | CZK 20,979.23 | 0.08% up | 2% up | ||
| 128 | RepligenRGEN · Health Care | 14.7 | CZK 242.4B | CZK 3,792.36 | 1.38% down | 12% up | ||
| 129 | TG TherapeuticsTGTX · Health Care | 15.9 | CZK 218.4B | CZK 1,444.88 | 1.88% down | 117% up | ||
| 130 | Royalty PharmaRPRX · Health Care | 16.4 | CZK 867.2B | CZK 1,508.12 | 1.38% down | 79% up | ||
| 131 | Adaptive BiotechnologiesADPT · Health Care | 16.4 | CZK 101.1B | CZK 624.67 | 1.44% down | 74% up | ||
| 132 | NateraNTRA · Health Care | 18.2 | CZK 936.2B | CZK 6,456.52 | 0.15% up | 28% up | ||
| 133 | Eli LillyLLY · Health Care | 18.5 | CZK 26.8T | CZK 30,089.44 | 2.29% down | 33% up | ||
| 134 | Guardant HealthGH · Health Care | 20.1 | CZK 438.6B | CZK 3,242.29 | 0.31% up | 45% up | ||
| 135 | Twist BioscienceTWST · Health Care | 20.2 | CZK 169.5B | CZK 2,485.78 | 4.07% down | 346% up | ||
| 136 | Ascendis PharmaASND · Health Care | 21.0 | CZK 373.9B | CZK 5,700.23 | 5.32% down | 29% up | ||
| 137 | Ligand PharmaceuticalsLGND · Health Care | 21.4 | CZK 127.8B | CZK 6,390.15 | 3.94% down | 50% up | ||
| 138 | HeartflowHTFL · Health Care | 22.3 | CZK 87.4B | CZK 993.91 | 2.75% down | 66% up | ||
| 139 | Krystal BiotechKRYS · Health Care | 24.1 | CZK 208.4B | CZK 7,033.31 | 0.15% up | 54% up | ||
| 140 | GlaukosGKOS · Health Care | 27.8 | CZK 313.9B | CZK 5,302.49 | 2.15% up | 145% up | ||
| 141 | WatersWAT · Health Care | 28.3 | CZK 2T | CZK 10,165.81 | 2.06% down | 23% up | ||
| 142 | BridgeBio PharmaBBIO · Health Care | 30.3 | CZK 339.2B | CZK 1,741.07 | 0.22% up | 21% up | ||
| 143 | GRAILGRAL · Health Care | 32.0 | CZK 105B | CZK 2,334.79 | 2.68% up | 19% up | ||
| 144 | ModernaMRNA · Health Care | 41.5 | CZK 1.8T | CZK 4,439.08 | 1.29% up | 780% up | ||
| 145 | Rhythm PharmaceuticalsRYTM · Health Care | 42.7 | CZK 180.3B | CZK 2,601.14 | 1.88% down | 18% up | ||
| 146 | InsmedINSM · Health Care | 52.3 | CZK 705.8B | CZK 3,217.12 | 20.58% up | 40% down | ||
| 147 | ImmunityBioIBRX · Health Care | 61.7 | CZK 155.7B | CZK 146.31 | 1.94% down | 232% up | ||
| 148 | CytokineticsCYTK · Health Care | 81.4 | CZK 159.6B | CZK 1,146.01 | 0.27% up | 19% down | ||
| 149 | Protagonist TherapeuticsPTGX · Health Care | 176 | CZK 180.3B | CZK 2,761.93 | 2.47% down | 51% up | ||
| 150 | Kymera TherapeuticsKYMR · Health Care | 260 | CZK 227B | CZK 2,658.82 | 1.44% down | 87% up | ||
| 151 | CRISPR TherapeuticsCRSP · Health Care | 1076 | CZK 84.1B | CZK 866.97 | 3.14% down | 18% down | ||
| 152 | CG OncologyCGON · Health Care | 1811 | CZK 162.9B | CZK 1,823.91 | 2.38% up | 97% up | ||
| 153 | Dianthus TherapeuticsDNTH · Health Care | 2346 | CZK 106.4B | CZK 1,889.16 | 1.01% up | 108% up | ||
| 154 | Roivant SciencesROIV · Health Care | 3418 | CZK 628.7B | CZK 867.64 | 0.59% up | 91% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2700 CZK). 16 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which health care companies have the lowest P/S ratio?
Centene (0.2), Cencora (0.2) and Molina Healthcare (0.2) have the lowest P/S ratio of the 154 health care companies ranked here as of 19 Nov 2026, 21:37 UTC.
How many health care companies are in this ranking?
154 are ranked by P/S ratio. 16 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 154 health care companies ranked by P/S ratio have a combined market value of CZK 198.68T as of 19 Nov 2026, 21:37 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/S ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.